WTA
GLSI icon

Washington Trust Advisors’s Greenwich LifeSciences GLSI Stock Holding History

Washington Trust Advisors’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.8K Hold
200
– – ﹤0.01% 533
2025
Q4 		$4.2K Hold
200
– – ﹤0.01% 556
2025
Q3 		$1.99K Hold
200
– – ﹤0.01% 660
2025
Q2 		$1.81K Hold
200
– – ﹤0.01% 615
2025
Q1 		$1.91K Hold
200
– – ﹤0.01% 614
2024
Q4 		$2.25K Hold
200
– – ﹤0.01% 617
2024
Q3 		$2.87K Hold
200
– – ﹤0.01% 619
2024
Q2 		$3.45K Hold
200
– – ﹤0.01% 601
2024
Q1 		$3.99K Hold
200
– – ﹤0.01% 596
2023
Q4 		$2.1K Buy
+200
New +$2K ﹤0.01% 642

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Washington Trust Advisors's GLSI Position: Q1 2026 in Review

Washington Trust Advisors held its Greenwich LifeSciences (GLSI) position steady in Q1 2026 at 200 shares worth $4.8K. The position accounts for ﹤0.01% of the portfolio, ranked #533.

Washington Trust Advisors first reported a position in GLSI in Q4 2023 and has held it in 10 quarters since. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Washington Trust Advisors held 200 shares of Greenwich LifeSciences worth $4.8K as of Q1 2026.
  • Washington Trust Advisors left its Greenwich LifeSciences share count unchanged in Q1 2026.
  • Greenwich LifeSciences made up ﹤0.01% of Washington Trust Advisors's portfolio in Q1 2026, its #533 holding.
  • Washington Trust Advisors first reported a position in Greenwich LifeSciences in Q4 2023 and has held it in 10 quarters since.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Washington Trust Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.